Results from This Site: 51 - 60 of 64 total results for GlaxoSmithKline
  • withdrew mid-week, leaving rival GlaxoSmithKline with a clear path to conclude a deal. However, the British group also dropped its bid on Friday. Both companies indicated the high cost of the business
  • Meanwhile, former GlaxoSmithKline CEO Andrew Witty is the surprise choice to lead UnitedHealth Group's pharmacy benefits division Optum, which negotiates drug prices on behalf of insurers and employers.
  • GlaxoSmithKline and Reckitt Benckiser. Most observers expect RB to win the prize, since GSK would need the approval of its healthcare partner Novartis, which might not be forthcoming. Meanwhile, the simultaneous
  • trading standards regulator turned its attention to GlaxoSmithKline and Novartis. The Australian Competition & Consumer Commission began proceedings against their GSK Consumer Healthcare joint venture
  • GlaxoSmithKline's new CEO Emma Walmsley announced plans for a major overhaul of the group's prescription drug portfolio. She said GSK will scrap or sell around 30 current drug development programmes in
  • including GlaxoSmithKline and Reckitt Benckiser, have already expressed interest in adding additional assets, and Pfizer's unit could generate an offer of as much as $14bn if it were put on the market.
  • GlaxoSmithKline named former Novartis executive Brian McNamara as the new CEO of the GSK Consumer Healthcare entity, following Emma Walmsley's promotion to GSK global CEO. He previously headed the OTC
  • GlaxoSmithKline named Emma Walmsley as its next CEO. She will succeed Sir Andrew Witty in March 2017, becoming arguably the most powerful woman in the UK corporate sector. Although five other FTSE 100
  • GlaxoSmithKline is joining forces with tech developer Verily - a unit of Google parent Alphabet Inc - to develop "bioelectronic" medicines to combat diseases such as arthritis, diabetes and asthma. This
  • GlaxoSmithKline concluded a review of marketing for its consumer healthcare division, consolidating duties with nine of its main current partners and eliminating other agencies from the roster. Grey and

All rights reserved © Mind Advertising Ltd 1998-2019